Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← STLD Overview

STLD

Comprehensive rating breakdown across 5 fundamental factors + Stonvex quant engine.

  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News

Stonvex Quant Grades

Our proprietary 6-factor scoring engine: Volume, Volatility, News, Sentiment, Dollar Flow, Relative Strength.

Quant grades are available for tickers in our scored universe.

The information above is for educational and informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Rankings and scores are computed by Stonvex's proprietary algorithm and are not endorsed by any financial institution. Past performance does not guarantee future results. Always consult a licensed financial advisor before making investment decisions.

Stonvex

AI-powered stock research for US equities.

whgksdhr1111@naver.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results.

Factor Grades

Each factor is graded A+ to F based on underlying metrics compared to typical market ranges. Valuation favors lower multiples, Growth and Profitability favor higher figures, Momentum reflects price performance, and Financial Health measures balance sheet strength.

Analyst Consensus

All Fundamentals

B-

Overall Factor Grade

Composite of 5 factors · Score: 63/100

C+
Valuation
C
Growth
C
Profitability
B+
Momentum
A-
Financial Health

Valuation

Compares price multiples to typical market ranges

C+
59/100
P/E (TTM)23.97
P/S (TTM)1.56
P/B2.76
P/FCF43.43

Growth

Revenue and earnings momentum over multiple horizons

C
50/100
Revenue YoY3.63%
EPS YoY-18.30%
Revenue 5Y13.61%
EPS 5Y25.23%

Profitability

How efficiently the company converts revenue to profit

C
47/100
Gross Margin13.16%
Op Margin8.12%
Net Margin6.52%
ROE13.31%
ROA7.43%

Momentum

Short to long-term price performance trends

B+
79/100
YTD Return15.36%
3M Return13.54%
6M Return38.01%
1Y Return66.37%

Financial Health

Balance sheet strength and ability to service debt

A-
83/100
Current Ratio—
Quick Ratio1.29
Debt/Equity—
Interest Cov22.32

Analyst Consensus

Buy
Based on 20 analysts
Period: 2026-04-01
14 Buy (70%)6 Hold (30%)0 Sell (0%)
Rating Distribution
Strong Buy
5
Buy
9
Hold
6
Sell
0
Strong Sell
0
Trend
2026-04
14/6/0
2026-03
14/6/0
2026-02
14/6/0
2026-01
15/6/0

Fundamentals

Valuation
Market Cap
$28.32B
P/E (TTM)
23.97S&P avg ~22
P/S (TTM)
1.56S&P avg ~2.8
P/B
2.76S&P avg ~4.5
P/FCF
43.43S&P avg ~26
EPS (TTM)
$8.00
Book/sh
$61.34
Cash/sh
$5.27
Profitability
Gross Margin
13.16%avg ~45%
Operating Margin
8.12%avg ~15%
Net Margin
6.52%avg ~12%
ROE
13.31%avg ~18%
ROA
7.43%avg ~7%
ROI
9.19%
Payout Ratio
24.56%
FCF/sh
—
Growth & Health
Rev Growth YoY
3.63%
Rev Growth 5Y
13.61%
EPS Growth YoY
-18.30%
EPS Growth 5Y
25.23%
Current Ratio
—
Quick Ratio
1.29
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
1.43
52W High
$208.47
52W Low
$112.60
Avg Vol (10D)
971.1K
Avg Vol (3M)
1.28M
Div Yield
1.08%
Div/sh (TTM)
—
Analyst
Buy (20)
Price Performance
5D+10.32%
MTD+8.59%
3M+13.54%
6M+38.01%
YTD+15.36%
1Y+66.37%